Chronic Diseases Value, Affordability, and… Understanding the Full Value of Long-Acting Therapies: less is more? Read more
Health Technology Assessment… Value, Affordability, and… An Analysis of NICE’s Optimised Decisions from 2015 to 2024 Read more
Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Drug Development/R&D Economics of Innovation Competition The Importance of Diversity of Supply in Rare Diseases Markets Read more © VK Studio at stock.adobe.com
Back Bulletin September 2024 Drug shortages are worrying and widespread Read more Bulletin September 2024 Health economics in the spotlight Read more Bulletin August 2024 Driving healthcare change Read more Bulletin July 2024 Transforming dementia care Read more